The activation status of human macrophages presenting antigen determines the efficiency of Th17 responses
Authors:
- Peter GordonPGPeter Gordon
- Robert N. BarkerRBRobert N. Barker
- Heather M. WilsonHeather M. Wilson
Open Access
- 1 January 2015
- journal article
- Published by Elsevier in Immunobiology
- Vol. 220 (1) , 10-19
Abstract
No abstract availableKeywords
Funding Information
- Kidney Research UK (grant RP1/2012)
- NHS (grant 08/25)
This publication has 38 references indexed in Scilit:
- Protective and pathogenic functions of macrophage subsetsNature Reviews Immunology, 2011
- C-type lectins, fungi and Th17 responsesCytokine & Growth Factor Reviews, 2010
- Alternative Activation of Macrophages: Mechanism and FunctionsImmunity, 2010
- An Essential Role for the NLRP3 Inflammasome in Host Defense against the Human Fungal Pathogen Candida albicansCell Host & Microbe, 2009
- In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responsesProceedings of the National Academy of Sciences, 2009
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cellsJournal of Experimental Medicine, 2008
- Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytesProceedings of the National Academy of Sciences, 2007
- Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cellsNature Immunology, 2007
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005